Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic MSCs (MSV) for Lumbar Degenerative Disc Disease
NCT01860417Phase 2Completed
- Sponsor
- Red de Terapia Celular
- Start
- Jun 2013
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MSV in degenerative disc disease (DDD), sponsored by Red de Terapia Celular. Started Jun 2013; status: completed.
02
Drugs
MSV
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT01860417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860417.